These 4 Measures Indicate That Crane (NYSE:CR) Is Using Debt Reasonably Well

Simply Wall StNov 19 18:36

China Approves Double-Crane Pharma Unit's Supplementary Drug Application for Eye Drops

MT NewswiresNov 19 13:49

Stifel Downgrades Crane to Hold, Maintains Price Target to $176

BenzingaNov 18 22:14 · Ratings

Crane Analyst Ratings

BenzingaNov 18 22:11 · Ratings

Smiths Group (LSE:SMIN) Leverages John Crane and AI for Growth, Eyes Market Value Upside

Yahoo FinanceNov 18 09:09

Syndax Wins FDA Approval for Leukemia Drug Revumenib

Seeking AlphaNov 16 06:45